Association of diabetes, hypertension and obesity with cognitive impairment in adults
Open Access
- 1 January 2026
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 20, e20250471
Abstract
Cognitive impairment (CI) is prevalent in aging and affects the functionality and autonomy of individuals. Previous studies have demonstrated its association with metabolic diseases such as diabetes mellitus (DM), systemic arterial hypertension (SAH), hypercholesterolemia, and obesity. Still, the synergic association of these comorbidities in the Brazilian population has not yet been explored. Elucidating the magnitude of the relationship between metabolic diseases and CI informs the planning of more effective health care and attention strategies. Objective To investigate the association between DM, SAH, hypercholesterolemia and obesity and CI in adults aged 50 years or older. Methods Cross-sectional population-based study using data from the second wave of the Brazilian longitudinal study of aging — ELSI-Brazil (2019). A total of 6,449 participants with complete data on the variables of interest and who responded directly to the survey were included in the analysis. CI was defined using standardized test z-scores. Exposures were identified through self-reported medical diagnoses and waist circumference measurements. Results The combination of DM, hypertension, and obesity was associated with a 4% increase in the prevalence of CI. With the addition of hypercholesterolemia, this increase reached 10%. The isolated or combined presence of only two of these conditions was not associated with significant differences. Conclusion Among people aged 50 and over, CI is more prevalent in those with multiple metabolic alterations. In a scenario of aging and high burden of chronic diseases, the findings reinforce the urgency of integrated prevention and control strategies to contain CI.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
This publication has 20 references indexed in Scilit:
- The global macroeconomic burden of Alzheimer's disease and other dementias: estimates and projections for 152 countries or territoriesThe Lancet Global Health, 2024
- Dementia prevention, intervention, and care: 2024 report of the Lancet standing CommissionThe Lancet, 2024
- Socioeconomic determinants of cognition among older adults in the Brazilian longitudinal study of aging (ELSI-Brazil): a life-course approachSocial Psychiatry and Psychiatric Epidemiology, 2024
- Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021The Lancet, 2024
- Cardiometabolic disease, cognitive decline, and brain structure in middle and older ageAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2024
- Brazil facing ageing population challengesThe Lancet, 2023
- Cardiometabolic multimorbidity, lifestyle behaviours, and cognitive function: a multicohort studyThe Lancet Healthy Longevity, 2023
- Multimorbidity, Function, and Cognition in AgingClinics in Geriatric Medicine, 2020
- Dementia prevention, intervention, and careThe Lancet, 2017
- Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognitionBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009